LG

Lawrence Gozlan

Enlitic Inc | Non-Executive Chairman, Non-Executive Director
Mr Gozlan a biotechnology investor and advisor, is the Life Sciences Investment Manager at Jagen Pty Ltd, an international private investment organization. Lawrence is also the Chief Investment Officer and Founder of Scientia Capital, a specialized global investment fund focused exclusively on life sciences. He currently serves as a director on several private and public company boards in Australia and the United States.

Companies and Roles

Company
Title
Tenure
Since
ENL
ENL
Enlitic Inc
  • Non-Executive Chairman
  • Non-Executive Director
6yrs, 9mthSep 2019
ATH
ATH
Alterity Therapeutics Limited
  • Non-Executive Director
14yrs, 11mthAug 2011
OPT
OPT
Ceryvyn Therapeutics Limited
  • Non-Executive Director
5yrs, 11mthJul 2020
CYV
CYV
Ceryvyn Therapeutics Limited
  • Non-Executive Director
5yrs, 11mthJul 2020

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CYV
CYV
Ceryvyn Therapeutics Limited
17/06/26N/A045,500,000N/A
OPT
OPT
Ceryvyn Therapeutics Limited
17/06/26N/A045,500,000N/A
ATH
ATH
Alterity Therapeutics Limited
15/06/261,030,30490,9102,030,304N/A
ENL
ENL
Enlitic Inc
30/12/2560,241N/A9,655,988N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CYV
CYV
Ceryvyn Therapeutics Limited
17/06/26
Sell
1,877,357$0.015$28,160On-market trade
OPT
OPT
Ceryvyn Therapeutics Limited
17/06/26
Sell
1,877,357$0.015$28,160On-market trade
ATH
ATH
Alterity Therapeutics Limited
15/06/26
Issued
1,000,000$0.510$510,000Issue of options
CYV
CYV
Ceryvyn Therapeutics Limited
19/12/25
Issued
41,000,000$0.600$24,600,000Directors' share plan
OPT
OPT
Ceryvyn Therapeutics Limited
19/12/25
Issued
41,000,000$0.600$24,600,000Directors' share plan